HIV-Infected Lymphocytes Regulate Fibronectin Synthesis by TGFβ1 Secretion

Journal of Immunology

Volumn 172, Issue 5, 2004, Pages 3189-3195

  Pal, Sampa ^a   Schnapp, Lynn M ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL INTERACTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOFLUORESCENCE; LYMPH NODE; MOUSE; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SECRETION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 1342324586     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.5.3189     Document Type: Article

References (23)

1. Schacker, T. W., P. L. Nguyen, G. J. Beilman, S. Wolinsky, M. Larson, C. Reilly, and A. T. Haase. 2002. Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis. J. Clin. Invest. 110:1133.
2. Greco, G., S. Pal, R. Pasqualini, and L. M. Schnapp. 2002. Matrix fibronectin increases HIV stability and infectivity. J. Immunol. 168:5722.
3. + T lymphocytes. J. Immunol. 164:3236.
4. 1-integrin expression and fibronectin interaction profile of T lymphocytes in vitro infected with HIV. AIDS Res. Hum. Retroviruses 16:423.
5. Michaelson, J. E., J. D. Ritzenthaler, and J. Roman. 2002. Regulation of serum-induced fibronectin expression by protein kinases, cytoskeletal integrity, and CREB. Am. J. Physiol. 282:L291.
6. Abe, M., J. G. Harpel, C. N. Metz, I. Nunes, D. J. Loskutoff, and D. B. Rifkin. 1994. An assay for transforming growth factor-β using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal. Biochem. 216:276.
7. Derynck, R., and Y. E. Zhang. 2003. Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 425:577.
8. Kekow, J., W. Wachsman, J. A. McCutchan, M. Cronin, D. A. Carson, and M. Lotz. 1990. Transforming growth factor β and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection. Proc. Natl. Acad. Sci. USA 87:8321.
9. Lotz, M., and P. Seth. 1993. TGF beta and HIV infection. Ann. NY Acad. Sci. 685:501.
10. Taipale, J., J. Saharinen, and J. Keski-Oja. 1998. Extracellular matrix-associated transforming growth factor-β: role in cancer cell growth and invasion. Adv. Cancer Res. 75:87.
11. Itoh, S., M. Thorikay, M. Kowanetz, A. Moustakas, F. Itoh, C. H. Heldin, and P. ten Dijke. 2003. Elucidation of Smad requirement in transforming growth factor-β type I receptor-induced responses. J. Biol. Chem. 278:3751.
12. Isono, M., S. Chen, S. W. Hong, M. C. Iglesias-de la Cruz, and F. N. Ziyadeh. 2002. Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-β-induced fibronectin in mesangial cells. Biochem. Biophys. Res. Commun. 296:1356.
13. Hocevar, B. A., T. L. Brown, and P. H. Howe. 1999. TGF-β induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J. 18:1345.
14. Chen, M. M., A. Lam, J. A. Abraham, G. F. Schreiner, and A. H. Joly. 2000, CTGF expression is induced by TGF-β in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis. J. Mol. Cell. Cardiol. 32:1805.
15. 6 binds and activates latent TGF β1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96:319.
16. Chen, W., M. E. Frank, W. Jin, and S. M. Wahl. 2001. TGF-β released by apoptotic T cells contributes to an immunosuppressive milieu. Immunity 14:715.
17. da Cunha, A., R. W. Jackson, and L. Vitkovic. 1995. HIV-1 non-specifically stimulates production of transforming growth factor-β1 transfer in primary astrocytes. J. Neuroimmunol. 60:125.
18. Zauli, G., B. R. Davis, M. C. Re, G. Visani, G. Furlini, and M. La Placa. 1992. tat protein stimulates production of transforming growth factor-β1 by marrow macrophages: a potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppression. Blood 80:3036.
19. + T cells. J. Immunol. 168:2247.
20. Zhang, Z.-Q., T. Schuler, W. Cavert, D. W. Notermans, K. Gebhard, K. Henry, D. V. Havlir, H. F. Gunthard, J. K. Wong, S. Little, et al. 1999. Reversibility of the pathological changes in the follicular dendritic cell network with treatment of HIV-1 infection. Proc. Natl. Acad. Sci. USA 96:5169.
21. Poynard, T., J. McHutchison, M. Manns, C. Trepo, K. Lindsay, Z. Goodman, M. H. Ling, and J. Albrecht. 2002. Impact of pegylated interferon α-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 122:1303.
22. Iredale, J. P., R. C. Benyon, J. Pickering, M. McCullen, M. Northrop, S. Pawley, C. Hovell, and M. J. Arthur. 1998. Mechanisms of spontaneous resolution of rat liver fibrosis: hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J. Clin. Invest. 102:538.
23. Murphy, F. R., R. Issa, X. Zhou, S. Ratnarajah, H. Nagase, M. J. Arthur, C. Benyon, and J. P. Iredale. 2002. Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis. J. Biol. Chem. 277:11069.